Market Cap 11.81M
Revenue (ttm) 0.00
Net Income (ttm) -11.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.16
Volume 1,001,013
Avg Vol 1,613,476
Day's Range N/A - N/A
Shares Out 9.84M
Stochastic %K 37%
Beta 0.22
Analysts Strong Sell
Price Target $7.50

Company Profile

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 488 0460
Address:
1325 Avenue of Americas, 28th Floor, New York, United States
steven_glandsberg
steven_glandsberg Jul. 17 at 5:56 PM
$BCLI had to be them tapping ATM to fund trial - especially because of how it bounced back. Up from here
0 · Reply
AshvsEvilDead
AshvsEvilDead Jul. 17 at 5:20 PM
$BCLI yep only good could come from FDA, otherwise nothing has changed with funding or p3b. Buying opp from the looks of it. Someone just dumped a position?
0 · Reply
bigdave100
bigdave100 Jul. 17 at 5:19 PM
$BCLI good buy time
0 · Reply
afc2881
afc2881 Jul. 17 at 5:18 PM
$BCLI Must have been an Atm moment.
0 · Reply
Mulhollandr
Mulhollandr Jul. 17 at 5:17 PM
$BCLI only started watching again over the past few weeks. Seems like there is good news afoot. Is this a stop loss attack?
0 · Reply
bigdave100
bigdave100 Jul. 17 at 5:16 PM
$BCLI knuckles finally pulled the plug
0 · Reply
steven_glandsberg
steven_glandsberg Jul. 17 at 5:15 PM
$BCLI wtf just happened
0 · Reply
bigdave100
bigdave100 Jul. 17 at 5:14 PM
$BCLI what happened
0 · Reply
Pipemajors82
Pipemajors82 Jul. 17 at 1:29 PM
$BCLI https://www.facebook.com/share/16eFk9nUof/
0 · Reply
afc2881
afc2881 Jul. 17 at 1:16 PM
$BCLI Ash this would be a miracle for all pals. 🙏🏻🙏🏻
0 · Reply
Latest News on BCLI
BrainStorm Issues 2024 Letter to Shareholders

Dec 30, 2024, 8:00 AM EST - 7 months ago

BrainStorm Issues 2024 Letter to Shareholders


steven_glandsberg
steven_glandsberg Jul. 17 at 5:56 PM
$BCLI had to be them tapping ATM to fund trial - especially because of how it bounced back. Up from here
0 · Reply
AshvsEvilDead
AshvsEvilDead Jul. 17 at 5:20 PM
$BCLI yep only good could come from FDA, otherwise nothing has changed with funding or p3b. Buying opp from the looks of it. Someone just dumped a position?
0 · Reply
bigdave100
bigdave100 Jul. 17 at 5:19 PM
$BCLI good buy time
0 · Reply
afc2881
afc2881 Jul. 17 at 5:18 PM
$BCLI Must have been an Atm moment.
0 · Reply
Mulhollandr
Mulhollandr Jul. 17 at 5:17 PM
$BCLI only started watching again over the past few weeks. Seems like there is good news afoot. Is this a stop loss attack?
0 · Reply
bigdave100
bigdave100 Jul. 17 at 5:16 PM
$BCLI knuckles finally pulled the plug
0 · Reply
steven_glandsberg
steven_glandsberg Jul. 17 at 5:15 PM
$BCLI wtf just happened
0 · Reply
bigdave100
bigdave100 Jul. 17 at 5:14 PM
$BCLI what happened
0 · Reply
Pipemajors82
Pipemajors82 Jul. 17 at 1:29 PM
$BCLI https://www.facebook.com/share/16eFk9nUof/
0 · Reply
afc2881
afc2881 Jul. 17 at 1:16 PM
$BCLI Ash this would be a miracle for all pals. 🙏🏻🙏🏻
0 · Reply
AshvsEvilDead
AshvsEvilDead Jul. 17 at 1:02 PM
$BCLI Breaking News! FDA is reviewing the petition to reconsider approval!!!
3 · Reply
Knuckles30
Knuckles30 Jul. 17 at 2:26 AM
$BCLI [email protected] e mail the CEO
1 · Reply
Knuckles30
Knuckles30 Jul. 16 at 7:29 PM
$BCLI [email protected] E mail Marykay Turner for trial start date
1 · Reply
Knuckles30
Knuckles30 Jul. 16 at 7:26 PM
$BCLI When is the idiot required to report 2 nd quarter earnings? Thats when we will hear from the JACKASS
0 · Reply
Nesepas
Nesepas Jul. 16 at 4:18 PM
$BCLI Assuming half of 32,000 pALS in US receive NurOwn at the recommended dosage of 6 times per year, at a cost of $150,000/dose: 16,000 * 6 * $150,000 = $14.4B/year, more as pALS live longer. And, yes, there will be economies of scale that would bring the cost down but I've seen estimates of $200K-$250K per dose in the beginning. It seems that there may be a lot of vested interests against NurOwn, namely, insurance companies, states' Medicaid and even within the federal government. This is sad. BCLI needs to address cost and their plan for bringing it down.
1 · Reply
Nesepas
Nesepas Jul. 16 at 2:26 PM
$BCLI Does the FDA have to provide an answer, comment or address the NurOwn Citizens Petition? Is there a deadline for their reaction? This is a worthy cause, perhaps Mrs. Melania Trump can take it up and guide it through the bureaucracy.
1 · Reply
Pipemajors82
Pipemajors82 Jul. 16 at 12:41 PM
$BCLI, this is really criminal.
0 · Reply
Mobagri
Mobagri Jul. 16 at 11:57 AM
$BCLI we all need to come up with a petition to the SEC how this company has misled its investors and has the arrogance to not communicate what they are doing with our money other than paying themself. The petition should numerate all the misleading statements announced since years ago and let the SEC be the judge.
2 · Reply
Ghyjp
Ghyjp Jul. 16 at 10:42 AM
$BCLI Well looks like the "goat" is still here dragging people through its bad management and broken promises....not to mention its very successful strategy of saying less and less to investors. They must be doing something right because everyone stays!
2 · Reply
thres
thres Jul. 16 at 5:23 AM
$BCLI Lesley Krummel - Phase 3 Signed the approve Nurown Now petition to FDA. See extracts from her FB Testimony "I personally FELT it work in my body. I physically Experienced it in my body. I was TOLD by my personal neurologist with no ties to the brainstorm trial that he knew I was Stronger! I believe heart and soul NurOwn WORKS! Until someone is faced with ALS, they could never understand what it feels like to trip, fall, break ribs and both of your wrists. To hang on to walls to walk because you desperately want to keep walking. Using a walker and feeling so self-conscience. Having a colostomy and catheter by choice because you didn't want to sit in a diaper let alone have loved ones change it. You find yourself typing a Facebook post with your eyes begging for the chance to take a drug that worked. I will never understand how any person or group claiming to care about people with ALS bad mouth and condemn us the opportunity to live?" Sign the public petition at https://www.change.org/p/urge-fda-to-approve-nurown-treatment-for-als
0 · Reply
Strout100
Strout100 Jul. 16 at 2:41 AM
$BCLI From Cool hand luke--- what we have here, is a failure to communicate! Unfortunately it ends up very very bad for Luke, is that foretelling our fate?
0 · Reply
Kgra
Kgra Jul. 16 at 2:17 AM
$BCLI Dr. Marty Makary, the current FDA Commissioner, has been a strong advocate for leveraging real-world evidence (RWE) in regulatory decision-making. He has emphasized the importance of using RWE, which includes data from sources like electronic health records, medical claims data, and registries, to complement traditional clinical trials. Makary believes that RWE can help the FDA modernize its approach, particularly in areas where traditional trials may be impractical or insufficient, such as in rare diseases or late-stage cancers.
0 · Reply